These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 25311090)

  • 21. Cholecystokinin-8 sulfate modulates the anticonvulsant efficacy of vigabatrin in an experimental model of partial complex epilepsy in the rat.
    Ferraro G; Sardo P
    Epilepsia; 2009 Apr; 50(4):721-30. PubMed ID: 19220409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile.
    Camposano SE; Major P; Halpern E; Thiele EA
    Epilepsia; 2008 Jul; 49(7):1186-91. PubMed ID: 18479386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures.
    Krauss GL; Serratosa JM; Villanueva V; Endziniene M; Hong Z; French J; Yang H; Squillacote D; Edwards HB; Zhu J; Laurenza A
    Neurology; 2012 May; 78(18):1408-15. PubMed ID: 22517103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Vigabatrin in childhood epilepsy--personal experience].
    Zubcević S; Gavranović M; Catibusić F; Uzicanin S; Buljina A
    Med Arh; 1999; 53(3 Suppl 2):63-5. PubMed ID: 10758766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood.
    McDonald DG; Najam Y; Keegan MB; Whooley M; Madden D; McMenamin JB
    Seizure; 2005 Mar; 14(2):112-6. PubMed ID: 15694564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Registry initiated to characterize vision loss associated with vigabatrin therapy.
    Pellock JM; Faught E; Sergott RC; Shields WD; Burkhart GA; Krauss GL; Foroozan R; Wesche DL; Weinberg MA
    Epilepsy Behav; 2011 Dec; 22(4):710-7. PubMed ID: 21978471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vigabatrin increases human brain homocarnosine and improves seizure control.
    Petroff OA; Mattson RH; Behar KL; Hyder F; Rothman DL
    Ann Neurol; 1998 Dec; 44(6):948-52. PubMed ID: 9851440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Vigabatrin in the treatment of intractable focal epilepsy in children and adolescents. Two-year study].
    Kozik A; Ujma-Czapska B; Grotowska M
    Neurol Neurochir Pol; 2000; 34 Suppl 1():187-93. PubMed ID: 10768158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adrenocorticotropic hormone for the treatment of West Syndrome in children.
    Shumiloff NA; Lam WM; Manasco KB
    Ann Pharmacother; 2013 May; 47(5):744-54. PubMed ID: 23606552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid onset of seizure suppression with pregabalin adjunctive treatment in patients with partial seizures.
    Ramsay RE; Perucca E; Robbins J; Barrett JA; Spiegel K
    Epilepsia; 2009 Aug; 50(8):1891-8. PubMed ID: 19490035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New drugs in the treatment of childhood epilepsy: vigabatrin (study of 61 subjects)].
    Raucci U; Spalice A; Basile LA; Guardalà C; Nasta L; Terenzi S; Iannetti P
    Pediatr Med Chir; 1994; 16(6):575-8. PubMed ID: 7708543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vigabatrin in the treatment of complex partial seizures.
    Knott C; Panayiotopoulos CP
    Seizure; 1992 Sep; 1(3):167-72. PubMed ID: 1344762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long-term follow-up of childhood epilepsy treated with vigabatrin outside of clinical trials].
    Garaizar C; Martínez-González MJ; Fernández-Cuesta MA; Prats JM
    Rev Neurol; 1999 Aug 1-15; 29(3):201-7. PubMed ID: 10797902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lacosamide in refractory mixed pediatric epilepsy: a prospective add-on study.
    Rastogi RG; Ng YT
    J Child Neurol; 2012 Apr; 27(4):492-5. PubMed ID: 22467791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral MRI abnormalities associated with vigabatrin therapy.
    Pearl PL; Vezina LG; Saneto RP; McCarter R; Molloy-Wells E; Heffron A; Trzcinski S; McClintock WM; Conry JA; Elling NJ; Goodkin HP; de Menezes MS; Ferri R; Gilles E; Kadom N; Gaillard WD
    Epilepsia; 2009 Feb; 50(2):184-94. PubMed ID: 18783433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vigabatrin in pediatric epilepsy--an open study.
    Uldall P; Alving J; Gram L; Beck S
    J Child Neurol; 1991; Suppl 2():S38-44. PubMed ID: 1940123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vigabatrin in childhood epilepsy.
    Dulac O; Chiron C; Luna D; Cusmai R; Pajot N; Beaumont D; Mondragon S
    J Child Neurol; 1991; Suppl 2():S30-7. PubMed ID: 1940122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Quantitative Clinical Pharmacology in Pediatric Approval and Labeling.
    Mehrotra N; Bhattaram A; Earp JC; Florian J; Krudys K; Lee JE; Lee JY; Liu J; Mulugeta Y; Yu J; Zhao P; Sinha V
    Drug Metab Dispos; 2016 Jul; 44(7):924-33. PubMed ID: 27079249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicenter long-term safety and efficacy study of vigabatrin for refractory complex partial seizures: an update.
    Browne TR; Mattson RH; Penry JK; Smith DB; Treiman DM; Wilder BJ; Ben-Menachem E; McBride RG; Sherry KM
    Neurology; 1991 Mar; 41(3):363-4. PubMed ID: 2006001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response to vigabatrin in relation to seizure type.
    Michelucci R; Tassinari CA
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):119S-124S. PubMed ID: 2667603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.